title: Comparison of the effect of the same dose of a 4-weekly continuous erythropoietin receptor activator administered once every 2 or 4 weeks in hemodialysis patients.
authors.affiliation: Department of Nephrology, Daimon Clinic for Internal Medicine, Nephrology and Dialysis, Nonoichi, Japan. dai-clinic@m2.spacelan.ne.jp.
authors.forename: Shoichiro
authors.initials: S
authors.lastname: Daimon
mesh_terms: D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin; D011092:Polyethylene Glycols; D007501:Iron